Wealth Enhancement Advisory Services »

Adma Biologics shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $438k 63k 6.92
2025-12-31 $117k 6.1k 19.36
2025-09-30 $76k 5.4k 13.99

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
NVIDIA Corporation (NVDA)
Alps Etf Tr Smith Core Plus (SMTH)
Microsoft Corporation Put Option (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Msci Intl Moment (IMTM)
Micron Technology (MU)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Adma Biologics

BlackRock
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
Rubric Capital Management
Capital Research Global Investors
First Trust Advisors
Geode Capital Management
Caligan Partners
D. E. Shaw & Co
Dimensional Fund Advisors
Goldman Sachs Group
Nuveen
Duquesne Family Office
Morgan Stanley

View all funds holding Adma Biologics